Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
52°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
95.79
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
October 01, 2023
These companies are helping change medicine; they could make boatloads of money along the way.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 29, 2023
Via
Benzinga
Abbott Laboratories And More On CNBC's 'Final Trades'
September 29, 2023
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Innovator U.S.
Via
Benzinga
Want $500 in Passive Income? Invest $3,500 Into These 3 Dividend Stocks and Wait 4 Years
September 29, 2023
A basket of passive income opportunities in oil and gas, renewable energy, and healthcare.
Via
The Motley Fool
Abbott Laboratories Unusual Options Activity
September 28, 2023
Via
Benzinga
Looking At Abbott Laboratories's Recent Unusual Options Activity
September 25, 2023
Via
Benzinga
Abbott Stock: Bear vs. Bull
September 23, 2023
Abbott is a favorite of income-oriented investors, but is the price right?
Via
The Motley Fool
P/E Ratio Insights for Abbott Laboratories
September 22, 2023
Via
Benzinga
This Is What Whales Are Betting On Abbott Laboratories
September 20, 2023
Via
Benzinga
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle
September 28, 2023
Abbott and Dexcom stocks have tumbled as GLP-1 drugs have gripped the nation.
Via
Investor's Business Daily
3 Best Stocks to Buy in September and Hold Forever
September 24, 2023
Healthcare blue chip stocks with proven track records can be excellent long-term investments.
Via
The Motley Fool
3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought
September 21, 2023
Tech stocks were the primary fuel for a decades-long bull market, and these three Nasdaq stocks to buy can lead the market forward.
Via
InvestorPlace
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
(ABT) - Analyzing Abbott Laboratories's Short Interest
September 20, 2023
Via
Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
September 14, 2023
Via
Benzinga
Is Abbott Laboratories a Buy?
September 12, 2023
If you're willing to invest with the right mindset, it could be a great option.
Via
The Motley Fool
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch
September 15, 2023
Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood...
Via
Benzinga
2 Dividend Kings to Buy on the Dip and Hold Forever
September 15, 2023
Don't ignore these stocks just because the rest of the market is.
Via
The Motley Fool
Why Jim Cramer Warns Investors To Avoid This Stock Up Over 90% This Year
September 15, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc. (NYSE: PATH) is a "decent" stock. Cramer said the company is not making money, and he doesn’t recommend stocks that don’t make money.
Via
Benzinga
Could Abbott Laboratories Stock Help You Become a Millionaire?
September 15, 2023
One promising area of its business is diabetes care, which experienced significant growth this year.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 11, 2023
Via
Benzinga
Looking At Abbott Laboratories's Recent Unusual Options Activity
September 06, 2023
Via
Benzinga
2 Incredible Stocks to Buy on the Dip
September 02, 2023
Today's bargain may pay off big down the road.
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
September 09, 2023
You'll want to hold on to these players for the long term.
Via
The Motley Fool
September Rally? 3 Healthcare Stocks to Buy Before Liftoff.
September 08, 2023
The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term.
Via
InvestorPlace
The 3 Best Pharma Stocks to Buy Now: September 2023
September 08, 2023
There are pharma stocks to buy for each type of investor. This article explores the best options in the industry.
Via
InvestorPlace
Down 10.3%, Is Abbott Laboratories Stock a Buy on the Dip?
September 05, 2023
Its latest pullback could be an opportunity to buy a legendary dividend stock before it begins a long upward climb.
Via
The Motley Fool
The 3 Most Promising Healthcare Stocks to Own Now
September 01, 2023
These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products.
Via
InvestorPlace
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
September 01, 2023
Via
Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
August 31, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.